Industry Key Highlights
According to TechSci Research report, “Artificial Intelligence Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F, The Global Artificial Intelligence Market was valued at USD 275.59 billion in 2024 and is expected to reach USD 1478.99 billion by 2030 with a CAGR of 32.32% through 2030. This explosive growth trajectory reflects the strategic shift in global enterprises towards digital automation, real-time analytics, autonomous decision-making, and data-driven innovation.
Request For Sample Copy of Report For More Detailed Market insight: https://www.techsciresearch.com/sample-report.aspx?cid=14621#requestform
Several forces are converging to drive this acceleration: increasing computational power, abundance of big data, maturity of machine learning (ML) algorithms, and expansion of edge AI capabilities. Meanwhile, the market is not just growing in scale—it’s evolving in sophistication. AI applications are becoming increasingly domain-specific, ethical AI is receiving widespread attention, and AI governance frameworks are being formalized globally.
From transforming manufacturing with predictive maintenance and quality control to revolutionizing healthcare with personalized diagnostics, the applications of AI are expanding into every sector imaginable. The emergence of generative AI, the convergence of AI with IoT, and the demand for hyper-personalized experiences further amplify the relevance of AI solutions in a highly competitive and fast-changing digital economy.
Emerging Trends in the AI Market
1. Edge AI: Intelligence Beyond the Cloud
A transformative trend reshaping the AI ecosystem is the deployment of AI at the edge. Instead of relying on centralized data centers, businesses are embedding AI into local devices—drones, sensors, smart cameras, and industrial equipment. This reduces latency, ensures operational continuity in low-connectivity environments, and facilitates real-time decision-making.
Industries such as logistics, agriculture, and healthcare are integrating edge AI to enable autonomous inspections, anomaly detection, energy optimization, and real-time medical diagnostics. As the number of connected devices surpasses tens of billions, edge AI becomes essential in distributing intelligence and reducing dependence on cloud-only architectures.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on the "Global Artificial Intelligence Market"@https://www.techsciresearch.com/report/artificial-intelligence-market/14621.html
2. AI and IoT Convergence
The fusion of Artificial Intelligence with the Internet of Things (AIoT) is unlocking powerful new use cases in industrial automation, smart homes, precision farming, and supply chain intelligence. AI interprets the deluge of data generated by IoT devices, turning raw metrics into actionable insights.
For instance, smart factories now use AI-driven IIoT networks to automate production lines, manage equipment maintenance, and optimize energy usage. As IoT networks expand, the need for adaptive AI models that evolve with changing data patterns is surging, enabling intelligent infrastructure management and autonomous ecosystems.
3. Responsible & Ethical AI
With AI systems influencing hiring decisions, credit assessments, healthcare recommendations, and public services, ethical considerations are taking center stage. Governments and industry leaders are investing in frameworks for fairness, transparency, and accountability in AI applications.
This includes regulations around bias mitigation, explainable AI, data privacy, and human oversight. The shift from “what AI can do” to “what AI should do” is redefining development processes and giving rise to AI auditing tools, algorithmic transparency platforms, and responsible innovation cultures.
4. Generative AI's Exponential Rise
Generative AI—encompassing technologies like ChatGPT, DALL·E, and Codex—is enabling machines to create text, images, code, and music. These tools are disrupting content creation, customer service, education, and entertainment.
Enterprises are adopting generative AI to build virtual assistants, automate documentation, personalize user interactions, and accelerate product design. With evolving natural language processing (NLP) capabilities, generative AI is expected to play a pivotal role in reshaping creativity, communication, and learning paradigms.
5. AI Democratization and No-Code/Low-Code Platforms
The rise of AI-as-a-Service (AIaaS) and no-code/low-code platforms is making AI development accessible to non-technical users. Business users can now build AI-powered applications without writing complex code, enabling faster innovation cycles.
This democratization is fueling AI adoption among small businesses, non-profits, and government agencies, expanding the market base and accelerating AI-powered transformation across sectors.
Market Drivers Fueling Growth
1. Expanding Digital Transformation Initiatives
As organizations strive to stay competitive, AI is becoming the backbone of digital transformation strategies. From chatbots in customer service to predictive analytics in finance, AI is delivering automation, accuracy, and agility.
2. Massive Data Generation
The explosion of data from online transactions, connected devices, social platforms, and enterprise systems is creating fertile ground for AI. Machine learning algorithms thrive on data, making today’s data-rich environments ideal for AI development.
3. Cloud AI Adoption
Cloud infrastructure is making AI more scalable and affordable. Enterprises are leveraging cloud-based AI platforms to process large datasets, run advanced ML models, and integrate AI into everyday operations.
4. AI in Cybersecurity
AI is increasingly used in cybersecurity solutions to detect threats, analyze anomalies, and respond to attacks in real-time. As cyber threats grow more sophisticated, AI’s role in digital defense will become even more critical.
5. Personalized Customer Experiences
AI enables hyper-personalization across retail, entertainment, and finance by analyzing customer behavior and preferences. Personalized product recommendations, dynamic pricing models, and tailored marketing campaigns are driving business growth and customer loyalty.
Competitive Analysis
The Global Artificial Intelligence Market is characterized by intense competition among tech giants, specialized startups, and cloud platform providers. Innovation, research capabilities, strategic partnerships, and data access define the competitive edge.
Key Players Include:
Startups and regional players are also disrupting niche verticals such as AI for legal tech, agriculture, and mental health, leveraging agility and domain expertise to compete.
Customers can also request for 10% free customization on this report.
Future Outlook
The outlook for the Artificial Intelligence Market through 2030 is incredibly promising. Advancements in neural networks, federated learning, autonomous systems, and quantum computing will continue to push boundaries.
We foresee:
Contact US:
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.
Click here to know more on Non-Small Cell Lung Cancer pipeline NSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many othersKey Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.Market DriverMarket Barrier The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.Detailed Non-Small Cell Lung Cancer market size by therapies, covering the United States, EU5 and Japan from 2017-2030.Reimbursement scenario and Key Opinion Leader Views Table of ContentsKey InsightsExecutive Summary of NSCLCSWOT Analysis of NSCLCNSCLC: Market Overview at a Glance4.1.
Total Market size of NSCLC in JapanALK-Mutation—Market Size21.1.
Report MethodologyDelveInsight CapabilitiesDisclaimerAbout DelveInsight Request a Webex Demo to get a walk-through of the report: https://www.delveinsight.com/sample-request/non-small-cell-lung-cancer-marketRelated Reports:Non-Small Cell Lung Cancer Epidemiology Forecast to 2030Non-Small Cell Lung Cancer Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020Non-Small Cell Lung Cancer Pipeline Insights, 2020About DelveInsightDelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the life science segment.
